GPT and Hepatic fibrosis: Our study showed consistent benefits of Silibinin on several key endpoints, including liver functions (AST, ALT, GGT, TBIL), lipid levels (TG, TC), coagulation indicators (PT), liver fibrosis indicators (PC-III), and improvement in effectiveness, with SMD ranging from moderate to significant (0.01–1.69).